Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 109 entries
Sorted by: Best Match Show Resources per page
Contrast Media Injector Technology - Renal Safety During Coronarography.

Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH

Mujicic E, Kevric E, Rasic S, Selimovic A, Granov N, Music D.
PMID: 26635433
Acta Inform Med. 2015 Oct;23(5):273-5. doi: 10.5455/aim.2015.23.273-275. Epub 2015 Oct 05.

AIM: This study sought to assess whether the volume and osmolarity of contrast media (CM) influences the occurrence of contrast induced nephropathy (CIN) following coronarography procedure. CIN can be defined as an increase in the serum concentration of creatinine...

Cite
Mujicic E, Kevric E, Rasic S, et al. Contrast Media Injector Technology - Renal Safety During Coronarography. Acta Inform Med. 2015;23(5):273-5doi: 10.5455/aim.2015.23.273-275.
Mujicic, E., Kevric, E., Rasic, S., Selimovic, A., Granov, N., & Music, D. (2015). Contrast Media Injector Technology - Renal Safety During Coronarography. Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH, 23(5), 273-5. https://doi.org/10.5455/aim.2015.23.273-275
Mujicic, Ermina, et al. "Contrast Media Injector Technology - Renal Safety During Coronarography." Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH vol. 23,5 (2015): 273-5. doi: https://doi.org/10.5455/aim.2015.23.273-275
Mujicic E, Kevric E, Rasic S, Selimovic A, Granov N, Music D. Contrast Media Injector Technology - Renal Safety During Coronarography. Acta Inform Med. 2015 Oct;23(5):273-5. doi: 10.5455/aim.2015.23.273-275. Epub 2015 Oct 05. PMID: 26635433; PMCID: PMC4639354.
Copy Download .nbib Format: NLM
Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors.

Molecular therapy. Methods & clinical development

Dias Florencio G, Precigout G, Beley C, Buclez PO, Garcia L, Benchaouir R.
PMID: 26207258
Mol Ther Methods Clin Dev. 2015 Jul 15;2:15024. doi: 10.1038/mtm.2015.24. eCollection 2015.

Recombinant adeno-associated viruses (rAAV) are promising candidates for gene therapy approaches. The last two decades were particularly fruitful in terms of processes applied in the production and purification of this type of gene transfer vectors. This rapid technological evolution...

Cite
Dias Florencio G, Precigout G, Beley C, et al. Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors. Mol Ther Methods Clin Dev. 2015;2:15024doi: 10.1038/mtm.2015.24.
Dias Florencio, G., Precigout, G., Beley, C., Buclez, P. O., Garcia, L., & Benchaouir, R. (2015). Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors. Molecular therapy. Methods & clinical development, 215024. https://doi.org/10.1038/mtm.2015.24
Dias Florencio, Gabriella, et al. "Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors." Molecular therapy. Methods & clinical development vol. 2 (2015): 15024. doi: https://doi.org/10.1038/mtm.2015.24
Dias Florencio G, Precigout G, Beley C, Buclez PO, Garcia L, Benchaouir R. Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors. Mol Ther Methods Clin Dev. 2015 Jul 15;2:15024. doi: 10.1038/mtm.2015.24. eCollection 2015. PMID: 26207258; PMCID: PMC4502676.
Copy Download .nbib Format: NLM
Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system.

Molecular therapy. Methods & clinical development

Buclez PO, Dias Florencio G, Relizani K, Beley C, Garcia L, Benchaouir R.
PMID: 27226971
Mol Ther Methods Clin Dev. 2016 May 11;3:16035. doi: 10.1038/mtm.2016.35. eCollection 2016.

Recombinant adeno-associated viruses (rAAV) are largely used for gene transfer in research, preclinical developments, and clinical trials. Their broad in vivo biodistribution and long-term efficacy in postmitotic tissues make them good candidates for numerous gene transfer applications. Upstream processes...

Cite
Buclez PO, Dias Florencio G, Relizani K, et al. Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system. Mol Ther Methods Clin Dev. 2016;3:16035doi: 10.1038/mtm.2016.35.
Buclez, P. O., Dias Florencio, G., Relizani, K., Beley, C., Garcia, L., & Benchaouir, R. (2016). Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system. Molecular therapy. Methods & clinical development, 316035. https://doi.org/10.1038/mtm.2016.35
Buclez, Pierre-Olivier, et al. "Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system." Molecular therapy. Methods & clinical development vol. 3 (2016): 16035. doi: https://doi.org/10.1038/mtm.2016.35
Buclez PO, Dias Florencio G, Relizani K, Beley C, Garcia L, Benchaouir R. Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system. Mol Ther Methods Clin Dev. 2016 May 11;3:16035. doi: 10.1038/mtm.2016.35. eCollection 2016. PMID: 27226971; PMCID: PMC4867670.
Copy Download .nbib Format: NLM
Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus.

Hepatology research : the official journal of the Japan Society of Hepatology

Matsumura T, Sugiyama N, Murayama A, Yamada N, Shiina M, Asabe S, Wakita T, Imawari M, Kato T.
PMID: 26606891
Hepatol Res. 2016 Aug;46(9):924-32. doi: 10.1111/hepr.12627. Epub 2016 Feb 04.

AIM: Although recent studies indicate that supplementation with vitamin D (VD) potentiates a sustained viral response by interferon-based therapy to chronic hepatitis C, detailed mechanisms are not fully defined. The production of cathelicidin, an antimicrobial peptide, has been demonstrated...

Cite
Matsumura T, Sugiyama N, Murayama A, et al. Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus. Hepatol Res. 2016;46(9):924-32doi: 10.1111/hepr.12627.
Matsumura, T., Sugiyama, N., Murayama, A., Yamada, N., Shiina, M., Asabe, S., Wakita, T., Imawari, M., & Kato, T. (2016). Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus. Hepatology research : the official journal of the Japan Society of Hepatology, 46(9), 924-32. https://doi.org/10.1111/hepr.12627
Matsumura, Takuya, et al. "Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,9 (2016): 924-32. doi: https://doi.org/10.1111/hepr.12627
Matsumura T, Sugiyama N, Murayama A, Yamada N, Shiina M, Asabe S, Wakita T, Imawari M, Kato T. Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus. Hepatol Res. 2016 Aug;46(9):924-32. doi: 10.1111/hepr.12627. Epub 2016 Feb 04. PMID: 26606891.
Copy Download .nbib Format: NLM
CT imaging of the eustachian tube using focal contrast medium administration: a feasibility study.

Laryngoscope investigative otolaryngology

Falkenberg-Jensen B, Silvola J, Laurvik H, Lervik A, Kristiansen JF, Jablonski G, Hopp E.
PMID: 28894806
Laryngoscope Investig Otolaryngol. 2016 Jun 28;1(4):83-87. doi: 10.1002/lio2.24. eCollection 2016 Aug.

OBJECTIVES: We aim to develop an imaging technique for visualization of the Eustachian tube (ET) lumen.STUDY DESIGN: A prospective, experimental study in an animal model and in human cadaver specimens.METHODS: Applying iodixanol to the middle ear in two human...

Cite
Falkenberg-Jensen B, Silvola J, Laurvik H, et al. CT imaging of the eustachian tube using focal contrast medium administration: a feasibility study. Laryngoscope Investig Otolaryngol. 2016;1(4):83-87doi: 10.1002/lio2.24.
Falkenberg-Jensen, B., Silvola, J., Laurvik, H., Lervik, A., Kristiansen, J. F., Jablonski, G., & Hopp, E. (2016). CT imaging of the eustachian tube using focal contrast medium administration: a feasibility study. Laryngoscope investigative otolaryngology, 1(4), 83-87. https://doi.org/10.1002/lio2.24
Falkenberg-Jensen, Benedicte, et al. "CT imaging of the eustachian tube using focal contrast medium administration: a feasibility study." Laryngoscope investigative otolaryngology vol. 1,4 (2016): 83-87. doi: https://doi.org/10.1002/lio2.24
Falkenberg-Jensen B, Silvola J, Laurvik H, Lervik A, Kristiansen JF, Jablonski G, Hopp E. CT imaging of the eustachian tube using focal contrast medium administration: a feasibility study. Laryngoscope Investig Otolaryngol. 2016 Jun 28;1(4):83-87. doi: 10.1002/lio2.24. eCollection 2016 Aug. PMID: 28894806; PMCID: PMC5510249.
Copy Download .nbib Format: NLM
Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis.

Cardiorenal medicine

McCullough PA, Brown JR.
PMID: 22164156
Cardiorenal Med. 2011;1(4):220-234. doi: 10.1159/000332384. Epub 2011 Oct 04.

BACKGROUND: The iso-osmolar contrast agent iodixanol may be associated with a lower incidence of contrast-induced acute kidney injury (CI-AKI) than low-osmolar contrast media (LOCM), but previous meta-analyses have yielded mixed results. Objectives: To compare the incidence of CI-AKI between...

Cite
McCullough PA, Brown JR. Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis. Cardiorenal Med. 2011;1(4):220-234doi: 10.1159/000332384.
McCullough, P. A., & Brown, J. R. (2011). Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis. Cardiorenal medicine, 1(4), 220-234. https://doi.org/10.1159/000332384
McCullough, Peter A, and Brown, Jeremiah R. "Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis." Cardiorenal medicine vol. 1,4 (2011): 220-234. doi: https://doi.org/10.1159/000332384
McCullough PA, Brown JR. Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis. Cardiorenal Med. 2011;1(4):220-234. doi: 10.1159/000332384. Epub 2011 Oct 04. PMID: 22164156; PMCID: PMC3222111.
Copy Download .nbib Format: NLM
Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide.

Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society

Gharekhanloo F, Torabian S.
PMID: 23329965
Iran J Radiol. 2012 Jun;9(2):63-6. doi: 10.5812/iranjradiol.7696. Epub 2012 Jun 30.

BACKGROUND: Iodinated X-ray contrast media are the most commonly used contrast agents in the world with an annual application of 40-50 million. New non-ionic contrast agents are subdivided into low osmolar agents such as iopromide and iso-osmolar agents such...

Cite
Gharekhanloo F, Torabian S. Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide. Iran J Radiol. 2012;9(2):63-6doi: 10.5812/iranjradiol.7696.
Gharekhanloo, F., & Torabian, S. (2012). Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide. Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society, 9(2), 63-6. https://doi.org/10.5812/iranjradiol.7696
Gharekhanloo, Farideh, and Torabian, Saadat. "Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide." Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society vol. 9,2 (2012): 63-6. doi: https://doi.org/10.5812/iranjradiol.7696
Gharekhanloo F, Torabian S. Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide. Iran J Radiol. 2012 Jun;9(2):63-6. doi: 10.5812/iranjradiol.7696. Epub 2012 Jun 30. PMID: 23329965; PMCID: PMC3522356.
Copy Download .nbib Format: NLM
Plaque imaging with CT coronary angiography: Effect of intra-vascular attenuation on plaque type classification.

World journal of radiology

Maffei E, Martini C, Arcadi T, Clemente A, Seitun S, Zuccarelli A, Torri T, Mollet NR, Rossi A, Catalano O, Messalli G, Cademartiri F.
PMID: 22778879
World J Radiol. 2012 Jun 28;4(6):265-72. doi: 10.4329/wjr.v4.i6.265.

AIM: To assess the attenuation of non-calcified atherosclerotic coronary artery plaques with computed tomography coronary angiography (CTCA).METHODS: Four hundred consecutive patients underwent CTCA (Group 1: 200 patients, Sensation 64 Cardiac, Siemens; Group 2: 200 patients, VCT GE Healthcare, with...

Cite
Maffei E, Martini C, Arcadi T, et al. Plaque imaging with CT coronary angiography: Effect of intra-vascular attenuation on plaque type classification. World J Radiol. 2012;4(6):265-72doi: 10.4329/wjr.v4.i6.265.
Maffei, E., Martini, C., Arcadi, T., Clemente, A., Seitun, S., Zuccarelli, A., Torri, T., Mollet, N. R., Rossi, A., Catalano, O., Messalli, G., & Cademartiri, F. (2012). Plaque imaging with CT coronary angiography: Effect of intra-vascular attenuation on plaque type classification. World journal of radiology, 4(6), 265-72. https://doi.org/10.4329/wjr.v4.i6.265
Maffei, Erica, et al. "Plaque imaging with CT coronary angiography: Effect of intra-vascular attenuation on plaque type classification." World journal of radiology vol. 4,6 (2012): 265-72. doi: https://doi.org/10.4329/wjr.v4.i6.265
Maffei E, Martini C, Arcadi T, Clemente A, Seitun S, Zuccarelli A, Torri T, Mollet NR, Rossi A, Catalano O, Messalli G, Cademartiri F. Plaque imaging with CT coronary angiography: Effect of intra-vascular attenuation on plaque type classification. World J Radiol. 2012 Jun 28;4(6):265-72. doi: 10.4329/wjr.v4.i6.265. PMID: 22778879; PMCID: PMC3391672.
Copy Download .nbib Format: NLM
Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular risk.

Nephron extra

Zanoli L, Rastelli S, Marcantoni C, Blanco J, Capodanno D, Tamburino C, Castellino P.
PMID: 22470377
Nephron Extra. 2011 Jan;1(1):38-44. doi: 10.1159/000329895. Epub 2011 Aug 16.

INTRODUCTION: The incidence of contrast-induced nephropathy (CIN) increases in high cardiovascular risk patients. Chronic kidney disease (CKD) is a known risk factor for CIN development. In a previous report, we demonstrated that the mean reference renal artery diameter (RVD)...

Cite
Zanoli L, Rastelli S, Marcantoni C, et al. Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular risk. Nephron Extra. 2011;1(1):38-44doi: 10.1159/000329895.
Zanoli, L., Rastelli, S., Marcantoni, C., Blanco, J., Capodanno, D., Tamburino, C., & Castellino, P. (2011). Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular risk. Nephron extra, 1(1), 38-44. https://doi.org/10.1159/000329895
Zanoli, Luca, et al. "Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular risk." Nephron extra vol. 1,1 (2011): 38-44. doi: https://doi.org/10.1159/000329895
Zanoli L, Rastelli S, Marcantoni C, Blanco J, Capodanno D, Tamburino C, Castellino P. Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular risk. Nephron Extra. 2011 Jan;1(1):38-44. doi: 10.1159/000329895. Epub 2011 Aug 16. PMID: 22470377; PMCID: PMC3290859.
Copy Download .nbib Format: NLM
Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography From Blood Plasma.

Frontiers in physiology

Onódi Z, Pelyhe C, Terézia Nagy C, Brenner GB, Almási L, Kittel Á, Manček-Keber M, Ferdinandy P, Buzás EI, Giricz Z.
PMID: 30405435
Front Physiol. 2018 Oct 23;9:1479. doi: 10.3389/fphys.2018.01479. eCollection 2018.

No abstract available.

Cite
Onódi Z, Pelyhe C, Terézia Nagy C, et al. Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography From Blood Plasma. Front Physiol. 2018;9:1479doi: 10.3389/fphys.2018.01479.
Onódi, Z., Pelyhe, C., Terézia Nagy, C., Brenner, G. B., Almási, L., Kittel, �. �., Manček-Keber, M., Ferdinandy, P., Buzás, E. I., & Giricz, Z. (2018). Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography From Blood Plasma. Frontiers in physiology, 91479. https://doi.org/10.3389/fphys.2018.01479
Onódi, Zsófia, et al. "Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography From Blood Plasma." Frontiers in physiology vol. 9 (2018): 1479. doi: https://doi.org/10.3389/fphys.2018.01479
Onódi Z, Pelyhe C, Terézia Nagy C, Brenner GB, Almási L, Kittel Á, Manček-Keber M, Ferdinandy P, Buzás EI, Giricz Z. Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography From Blood Plasma. Front Physiol. 2018 Oct 23;9:1479. doi: 10.3389/fphys.2018.01479. eCollection 2018. PMID: 30405435; PMCID: PMC6206048.
Copy Download .nbib Format: NLM
Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro.

Journal of experimental orthopaedics

Dallaudiere B, Crombé A, Gadeau AP, Pesquer L, Peuchant A, James C, Silvestre A.
PMID: 30374787
J Exp Orthop. 2018 Oct 29;5(1):47. doi: 10.1186/s40634-018-0162-4.

BACKGROUND: Iodine contrast agents (ICAs) are routinely used by radiologists to help guide intra-articular infiltrations. The aim of this study was to assess the in vitro effects of ICA on platelet function of human autologous Platelet-Rich Plasma (PRP).METHODS: One...

Cite
Dallaudiere B, Crombé A, Gadeau AP, et al. Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro. J Exp Orthop. 2018;5(1):47doi: 10.1186/s40634-018-0162-4.
Dallaudiere, B., Crombé, A., Gadeau, A. P., Pesquer, L., Peuchant, A., James, C., & Silvestre, A. (2018). Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro. Journal of experimental orthopaedics, 5(1), 47. https://doi.org/10.1186/s40634-018-0162-4
Dallaudiere, B, et al. "Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro." Journal of experimental orthopaedics vol. 5,1 (2018): 47. doi: https://doi.org/10.1186/s40634-018-0162-4
Dallaudiere B, Crombé A, Gadeau AP, Pesquer L, Peuchant A, James C, Silvestre A. Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro. J Exp Orthop. 2018 Oct 29;5(1):47. doi: 10.1186/s40634-018-0162-4. PMID: 30374787; PMCID: PMC6206314.
Copy Download .nbib Format: NLM
Angioplasty with Stenting in Acute Coronary Syndromes with Very Low Contrast Volume Using 6F Diagnostic Catheters and Bench Testing of Catheters.

Open access Macedonian journal of medical sciences

Arokiaraj MC.
PMID: 30976350
Open Access Maced J Med Sci. 2019 Mar 29;7(6):1004-1012. doi: 10.3889/oamjms.2019.238. eCollection 2019 Mar 30.

AIM: To safely perform angioplasties in acute coronary syndromes with low contrast volume using Cordis 6F diagnostic catheters and to perform mechanical bench tests on the diagnostic and guide catheters in a radial path model.METHODS: In 191 patients (242...

Cite
Arokiaraj MC. Angioplasty with Stenting in Acute Coronary Syndromes with Very Low Contrast Volume Using 6F Diagnostic Catheters and Bench Testing of Catheters. Open Access Maced J Med Sci. 2019;7(6):1004-1012doi: 10.3889/oamjms.2019.238.
Arokiaraj, M. C. (2019). Angioplasty with Stenting in Acute Coronary Syndromes with Very Low Contrast Volume Using 6F Diagnostic Catheters and Bench Testing of Catheters. Open access Macedonian journal of medical sciences, 7(6), 1004-1012. https://doi.org/10.3889/oamjms.2019.238
Arokiaraj, Mark Christopher. "Angioplasty with Stenting in Acute Coronary Syndromes with Very Low Contrast Volume Using 6F Diagnostic Catheters and Bench Testing of Catheters." Open access Macedonian journal of medical sciences vol. 7,6 (2019): 1004-1012. doi: https://doi.org/10.3889/oamjms.2019.238
Arokiaraj MC. Angioplasty with Stenting in Acute Coronary Syndromes with Very Low Contrast Volume Using 6F Diagnostic Catheters and Bench Testing of Catheters. Open Access Maced J Med Sci. 2019 Mar 29;7(6):1004-1012. doi: 10.3889/oamjms.2019.238. eCollection 2019 Mar 30. PMID: 30976350; PMCID: PMC6454170.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 109 entries